Annual CFF
-$271.00 K
-$15.74 M-101.75%
01 December 2023
Summary:
Creative Medical Technology Holdings annual cash flow from financing activities is currently -$271.00 thousand, with the most recent change of -$15.74 million (-101.75%) on 01 December 2023. During the last 3 years, it has fallen by -$964.90 thousand (-139.05%). CELZ annual CFF is now -101.75% below its all-time high of $15.47 million, reached on 31 December 2022.CELZ Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$25.50 K
+$41.10 K+61.71%
01 September 2024
Summary:
Creative Medical Technology Holdings quarterly cash flow from financing activities is currently -$25.50 thousand, with the most recent change of +$41.10 thousand (+61.71%) on 01 September 2024. Over the past year, it has increased by +$166.30 thousand (+86.70%). CELZ quarterly CFF is now -100.16% below its all-time high of $15.47 million, reached on 01 June 2022.CELZ Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$254.10 K
+$166.30 K+39.56%
01 September 2024
Summary:
Creative Medical Technology Holdings TTM cash flow from financing activities is currently -$254.10 thousand, with the most recent change of +$166.30 thousand (+39.56%) on 01 September 2024. Over the past year, it has dropped by -$62.30 thousand (-32.48%). CELZ TTM CFF is now -100.92% below its all-time high of $27.59 million, reached on 01 June 2022.CELZ TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CELZ Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -101.8% | +86.7% | -32.5% |
| 3 y3 years | -139.1% | -100.9% | -106.7% |
| 5 y5 years | -120.2% | -108.2% | -120.5% |
CELZ Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -101.8% | at low | -100.2% | +86.7% | -100.9% | +39.6% |
| 5 y | 5 years | -101.8% | at low | -100.2% | +86.7% | -100.9% | +39.6% |
| alltime | all time | -101.8% | at low | -100.2% | +86.7% | -100.9% | +39.6% |
Creative Medical Technology Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$25.50 K(-61.7%) | -$254.10 K(-39.6%) |
| June 2024 | - | -$66.60 K(-19.6%) | -$420.40 K(+18.8%) |
| Mar 2024 | - | -$82.80 K(+4.5%) | -$353.80 K(+30.6%) |
| Dec 2023 | -$271.00 K(-101.8%) | -$79.20 K(-58.7%) | -$271.00 K(+41.3%) |
| Sept 2023 | - | -$191.80 K(<-9900.0%) | -$191.80 K(<-9900.0%) |
| June 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2023 | - | $0.00(0.0%) | $15.47 M(0.0%) |
| Dec 2022 | $15.47 M(+20.5%) | $0.00(0.0%) | $15.47 M(-37.6%) |
| Sept 2022 | - | $0.00(-100.0%) | $24.78 M(-10.2%) |
| June 2022 | - | $15.47 M(>+9900.0%) | $27.59 M(+125.7%) |
| Mar 2022 | - | $0.00(-100.0%) | $12.22 M(-4.8%) |
| Dec 2021 | $12.84 M(+1750.6%) | - | - |
| Dec 2021 | - | $9.31 M(+231.2%) | $12.84 M(+239.1%) |
| Sept 2021 | - | $2.81 M(+2561.1%) | $3.79 M(+228.6%) |
| June 2021 | - | $105.60 K(-82.9%) | $1.15 M(-1.3%) |
| Mar 2021 | - | $618.60 K(+145.2%) | $1.17 M(+68.3%) |
| Dec 2020 | $693.90 K(-30.5%) | $252.30 K(+43.6%) | $693.90 K(+11.1%) |
| Sept 2020 | - | $175.70 K(+45.3%) | $624.40 K(-18.0%) |
| June 2020 | - | $120.90 K(-16.6%) | $761.10 K(+0.9%) |
| Mar 2020 | - | $145.00 K(-20.7%) | $754.20 K(-24.4%) |
| Dec 2019 | $997.70 K(-25.7%) | $182.80 K(-41.5%) | $997.60 K(-19.7%) |
| Sept 2019 | - | $312.40 K(+174.0%) | $1.24 M(-7.9%) |
| June 2019 | - | $114.00 K(-70.6%) | $1.35 M(-8.7%) |
| Mar 2019 | - | $388.40 K(-9.0%) | $1.48 M(+10.0%) |
| Dec 2018 | $1.34 M(+97.0%) | $426.90 K(+1.8%) | $1.34 M(+30.2%) |
| Sept 2018 | - | $419.30 K(+72.6%) | $1.03 M(+46.8%) |
| June 2018 | - | $243.00 K(-4.1%) | $702.20 K(-15.9%) |
| Mar 2018 | - | $253.50 K(+120.1%) | $834.90 K(+22.5%) |
| Dec 2017 | $681.50 K(+0.7%) | $115.20 K(+27.3%) | $681.40 K(-27.5%) |
| Sept 2017 | - | $90.50 K(-75.9%) | $940.00 K(-4.9%) |
| June 2017 | - | $375.70 K(+275.7%) | $988.10 K(+36.0%) |
| Mar 2017 | - | $100.00 K(-73.2%) | $726.30 K(+7.3%) |
| Dec 2016 | $677.00 K | $373.80 K(+169.7%) | $677.00 K(+122.3%) |
| Sept 2016 | - | $138.60 K(+21.7%) | $304.60 K(+80.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | $113.90 K(+124.7%) | $168.50 K(+182.7%) |
| Mar 2016 | - | $50.70 K(+3521.4%) | $59.60 K(+328.8%) |
| Dec 2015 | $13.90 K(-22.3%) | $1400.00(-44.0%) | $13.90 K(-20.6%) |
| Sept 2015 | - | $2500.00(-50.0%) | $17.50 K(-1.1%) |
| June 2015 | - | $5000.00(0.0%) | $17.70 K(-1.7%) |
| Mar 2015 | - | $5000.00(0.0%) | $18.00 K(0.0%) |
| Dec 2014 | $17.90 K(-20.4%) | $5000.00(+85.2%) | $18.00 K(+4.0%) |
| Sept 2014 | - | $2700.00(-49.1%) | $17.30 K(-5.5%) |
| June 2014 | - | $5300.00(+6.0%) | $18.30 K(-2.1%) |
| Mar 2014 | - | $5000.00(+16.3%) | $18.70 K(-17.3%) |
| Dec 2013 | $22.50 K(+37.2%) | $4300.00(+16.2%) | $22.60 K(+5.1%) |
| Sept 2013 | - | $3700.00(-35.1%) | $21.50 K(-2.3%) |
| June 2013 | - | $5700.00(-36.0%) | $22.00 K(+17.0%) |
| Mar 2013 | - | $8900.00(+178.1%) | $18.80 K(+14.6%) |
| Dec 2012 | $16.40 K(+12.3%) | $3200.00(-23.8%) | $16.40 K(+24.2%) |
| Sept 2012 | - | $4200.00(+68.0%) | $13.20 K(-12.0%) |
| June 2012 | - | $2500.00(-61.5%) | $15.00 K(-14.3%) |
| Mar 2012 | - | $6500.00(>+9900.0%) | $17.50 K(+19.0%) |
| Dec 2011 | $14.60 K(+8.1%) | $0.00(-100.0%) | $14.70 K(-16.9%) |
| Sept 2011 | - | $6000.00(+20.0%) | $17.70 K(0.0%) |
| June 2011 | - | $5000.00(+35.1%) | $17.70 K(+39.4%) |
| Mar 2011 | - | $3700.00(+23.3%) | $12.70 K(-5.9%) |
| Dec 2010 | $13.50 K(-56.5%) | $3000.00(-50.0%) | $13.50 K(-34.1%) |
| Sept 2010 | - | $6000.00(>+9900.0%) | $20.50 K(+5.1%) |
| June 2010 | - | $0.00(-100.0%) | $19.50 K(-45.1%) |
| Mar 2010 | - | $4500.00(-55.0%) | $35.50 K(+14.5%) |
| Dec 2009 | $31.00 K(+14.8%) | $10.00 K(+100.0%) | $31.00 K(+47.6%) |
| Sept 2009 | - | $5000.00(-68.8%) | $21.00 K(-53.6%) |
| June 2009 | - | $16.00 K(>+9900.0%) | $45.30 K(+67.2%) |
| Mar 2009 | - | $0.00(0.0%) | $27.10 K(0.0%) |
| Dec 2008 | $27.00 K(+80.0%) | $0.00(-100.0%) | $27.10 K(0.0%) |
| Sept 2008 | - | $29.30 K(-1431.8%) | $27.10 K(-1331.8%) |
| June 2008 | - | -$2200.00 | -$2200.00 |
| Dec 2007 | $15.00 K(+1400.0%) | - | - |
| Dec 2006 | $1000.00 | - | - |
FAQ
- What is Creative Medical Technology Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Creative Medical Technology Holdings?
- What is Creative Medical Technology Holdings annual CFF year-on-year change?
- What is Creative Medical Technology Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Creative Medical Technology Holdings?
- What is Creative Medical Technology Holdings quarterly CFF year-on-year change?
- What is Creative Medical Technology Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Creative Medical Technology Holdings?
- What is Creative Medical Technology Holdings TTM CFF year-on-year change?
What is Creative Medical Technology Holdings annual cash flow from financing activities?
The current annual CFF of CELZ is -$271.00 K
What is the all time high annual CFF for Creative Medical Technology Holdings?
Creative Medical Technology Holdings all-time high annual cash flow from financing activities is $15.47 M
What is Creative Medical Technology Holdings annual CFF year-on-year change?
Over the past year, CELZ annual cash flow from financing activities has changed by -$15.74 M (-101.75%)
What is Creative Medical Technology Holdings quarterly cash flow from financing activities?
The current quarterly CFF of CELZ is -$25.50 K
What is the all time high quarterly CFF for Creative Medical Technology Holdings?
Creative Medical Technology Holdings all-time high quarterly cash flow from financing activities is $15.47 M
What is Creative Medical Technology Holdings quarterly CFF year-on-year change?
Over the past year, CELZ quarterly cash flow from financing activities has changed by +$166.30 K (+86.70%)
What is Creative Medical Technology Holdings TTM cash flow from financing activities?
The current TTM CFF of CELZ is -$254.10 K
What is the all time high TTM CFF for Creative Medical Technology Holdings?
Creative Medical Technology Holdings all-time high TTM cash flow from financing activities is $27.59 M
What is Creative Medical Technology Holdings TTM CFF year-on-year change?
Over the past year, CELZ TTM cash flow from financing activities has changed by -$62.30 K (-32.48%)